Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Feb. 15, 2005

Novartis inlicenses rebamipide for dry eye

Feb. 9, 2005

Phase III confirmatory study of Photrex planned

Feb. 4, 2005

Pharmos receives milestone for Zylet launch

Jan. 26, 2005

Macugen now available

Jan. 25, 2005

Jerini and Alcon collaborate on novel ophthalmology drugs

Jan. 24, 2005

Phase II study evaluates recombinant microplasmin in vitreoretinal disorders

Jan. 21, 2005

Evidence suggests that retinitis pigmentosa may be caused by mutations in the CA4 gene

Jan. 17, 2005

Phase II data on the efficacy of squalamine in wet AMD

Jan. 13, 2005

ISTA launches Vitrase

Jan. 11, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...